New drugs of 2004.
OBJECTIVE
To provide information regarding the most important properties of the new therapeutic agents marketed in 2004.


METHODS
Product labeling supplemented selectively with published studies and drug information reference sources.


METHODS
By the author.


METHODS
By the author.


RESULTS
The 22 new therapeutic agents marketed in the United States during 2004 are reviewed in this article. Indications and information on dosage and administration for these agents are reviewed, as are the most important pharmacokinetic properties, adverse events, drug interactions, and other precautions. Practical considerations for the use of the new agents are also discussed. When possible, the properties of the new drugs are compared with those of older drugs marketed for the same indications.


CONCLUSIONS
A number of the new therapeutic agents marketed in 2004 have important advantages over older medications. An understanding of the properties of these agents is important for the pharmacist to effectively counsel patients about their use and to serve as a valuable source of information for other health professionals regarding these drugs.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of the Sciences Philadelphia, 600 South 43rd St., PA 19104-4495, USA. d.hussar@usip.edu
D017277:Drug Approval; D004513:Education, Pharmacy, Continuing / Q000379:methods / Q000592:standards / Q000639:trends; D006801:Humans; D004364:Pharmaceutical Preparations / Q000138:chemical synthesis / Q000145:classification*; D011356:Product Labeling / Q000331:legislation & jurisprudence / Q000379:methods; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence / Q000592:standards
D004364:Pharmaceutical Preparations